» Execs: Health AI widespread in 3 years
In its report, “AI and the Future of Healthcare,” Berkley Research Group found that three in four healthcare professionals surveyed believe that artificial intelligence-related technologies will be widespread within the next three years.
The findings were based on a survey and interviews of 150 healthcare professionals by BRG.
Although healthcare leaders already are preparing for new regulations, most say they are confident that future regulation and guidance will provide the necessary guardrails for proper implementation and use. Only four in 10 overall indicated that their organizations are reviewing or planning to review AI regulatory guidance. Investors spent $31.5 billion on healthcare AI between 2019 and 2022.
» Aging research program tackles AI
One of the country’s largest collaboratives in AI technology recently introduced itself to the long-term care community in an editorial published by the Journal of the American Geriatrics Society.
In the column “Empowering innovation in AI + AgeTech,” officials with the Artificial Intelligence and Technology Collaboratories for Aging Research program noted that it is the newest among seven centers under programs funded by the National Institute on Aging, a part of the National Institutes of Health.
The collaborative, with objectives that include “helping Americans live longer, healthier lives through the application of AI and emerging technologies,” was launched in September 2021.
» More older adults becoming comfortable with using tech to help them age in place
Although fewer older adults say their homes are equipped to allow them to age in place in 2024 compared with 2023, more of them are getting comfortable with the idea of using assistive or health-related technologies to keep them living where they are, according to the results of a US News & World Report survey.
Getting older (49%) is the main reason respondents cited for using assistive or health-related technologies, followed by mobility impairment (28%) and hearing impairment (22%).
